The cross‐talks between PD‐1 and PD‐L1/PD‐L2[9, 10] or Fas and FasL1[11, 12] are ones of the main mechanisms contributing to such suppression or dysfunction applied to tumor‐specific CD8+ T cells. Here, PDCD1LG2 is linked to neoplasm.